Are you Dr. Lungu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Ks 406
Boston, MA 02215Phone+1 617-667-5583Fax+1 617-667-2987
Summary
- Dr. Codrin Lungu, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Maryland, and New York.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Neurology, 2004 - 2007
Nassau University Medical CenterInternship, Internal Medicine, 2003 - 2004
University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 2000
Certifications & Licensure
NY State Medical License 2006 - Present
MD State Medical License 2008 - 2026
MA State Medical License 2007 - 2011- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders Start of enrollment: 1989 Oct 26
- Phenotype/Genotype Correlations in Movement Disorders Start of enrollment: 2001 Oct 22
- Acetyl Hexapeptide-8 for Blepharospasm Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPersistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.John D Heiss, Abhik Ray-Chaudhury, David E Kleiner, Debra J Ehrlich, Gretchen Scott
Movement Disorders. 2024-08-01 - 4 citationsObjective response to ethanol in essential tremor: results from a standardized ethanol challenge study.Patrick McGurrin, Gina Norato, Johanna Thompson-Westra, Gayle McCrossin, Emily Lines
Annals of Clinical and Translational Neurology. 2024-01-01 - 18 citationsLong-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.Matthew T Rocco, Asad S Akhter, Debra J Ehrlich, Gretchen C Scott, Codrin Lungu
Molecular Therapy. 2022-12-07
Press Mentions
- Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated with MAPT, GRN, and C9orf72 Pathogenic VariantsOctober 1st, 2020
Vigorous Exercise May Help Slow Parkinson's DiseaseJune 27th, 2020
Parkinson’s Disease Symptoms: Sign in Your Handwriting May Signal the ConditionNovember 18th, 2019- Join now to see all
Professional Memberships
- Member
